Literature DB >> 30549484

Mask Off? Lithium Augmentation for Clozapine Rechallenge After Neutropenia or Agranulocytosis: Discontinuation Might Be Risky.

Mina Boazak1,2, David R Goldsmith3, Robert O Cotes3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30549484      PMCID： PMC6501577          DOI： 10.4088/PCC.18l02282

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  16 in total

1.  Safety and efficacy of combined clozapine-lithium pharmacotherapy.

Authors:  Stefan Bender; Thomas Linka; Jörg Wolstein; Susanne Gehendges; Hermann-Josef Paulus; Ulrich Schall; Markus Gastpar
Journal:  Int J Neuropsychopharmacol       Date:  2004-01-20       Impact factor: 5.176

2.  Case report of long-term lithium for treatment and prevention of clozapine-induced neutropenia in an African American male.

Authors:  Narsimha R Pinninti; Michael P Houdart; Eileen McNeill Strouse
Journal:  J Clin Psychopharmacol       Date:  2010-04       Impact factor: 3.153

3.  Lithium as a treatment of clozapine-induced neutropenia: a case report.

Authors:  Andre Russowsky Brunoni; Luiz Roberto Kobuti Ferreira; José Gallucci-Neto; Hélio Elkis; Elvira Deolinda Pereira Rodrigues Velloso; Marcus Vinicius Zanetti
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-09-12       Impact factor: 5.067

Review 4.  Lithium and hematology: established and proposed uses.

Authors:  Daniele Focosi; Antonio Azzarà; Richard Eric Kast; Giovanni Carulli; Mario Petrini
Journal:  J Leukoc Biol       Date:  2008-09-22       Impact factor: 4.962

Review 5.  Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.

Authors:  Eromona Whiskey; David Taylor
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 6.  When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.

Authors:  Peter Manu; Deepak Sarpal; Owen Muir; John M Kane; Christoph U Correll
Journal:  Schizophr Res       Date:  2011-11-22       Impact factor: 4.939

7.  Lithium and clozapine rechallenge: a retrospective case analysis.

Authors:  Richard A Kanaan; Robert W Kerwin
Journal:  J Clin Psychiatry       Date:  2006-05       Impact factor: 4.384

Review 8.  Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.

Authors:  Maria Rosaria A Muscatello; Antonio Bruno; Pasquale De Fazio; Cristina Segura-Garcia; Gianluca Pandolfo; Rocco Zoccali
Journal:  Expert Opin Pharmacother       Date:  2014-10-05       Impact factor: 3.889

9.  Clozapine-induced neutropenia in children: management with lithium carbonate.

Authors:  Alexandra Sporn; Nitin Gogtay; Roberto Ortiz-Aguayo; Cara Alfaro; Julia Tossell; Marge Lenane; Peter Gochman; Judith L Rapoport
Journal:  J Child Adolesc Psychopharmacol       Date:  2003       Impact factor: 2.576

10.  [Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs].

Authors:  A Sénéchal; P Landry; R Deschamps; M Lessard
Journal:  Encephale       Date:  2002 Nov-Dec       Impact factor: 1.291
View more
  6 in total

1.  Never Say Never: Successful Clozapine Rechallenge After Multiple Episodes of Neutropenia.

Authors:  Michael Shuman; Lori Moss; Adam Dilich
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-01-25

Review 2.  Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide.

Authors:  Edward Silva; Melanie Higgins; Barbara Hammer; Paul Stephenson
Journal:  BMC Psychiatry       Date:  2020-06-05       Impact factor: 3.630

3.  Clozapine in the treatment of refractory schizophrenia: a practical guide for healthcare professionals.

Authors:  R J Flanagan; J Lally; S Gee; R Lyon; S Every-Palmer
Journal:  Br Med Bull       Date:  2020-10-14       Impact factor: 4.291

4.  In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine.

Authors:  Jurjen J Luykx; Noraly Stam; Antti Tanskanen; Jari Tiihonen; Heidi Taipale
Journal:  Br J Psychiatry       Date:  2020-09       Impact factor: 9.319

5.  Clozapine re-challenge and initiation following neutropenia: a review and case series of 14 patients in a high-secure forensic hospital.

Authors:  Edward Silva; Melanie Higgins; Barbara Hammer; Paul Stephenson
Journal:  Ther Adv Psychopharmacol       Date:  2021-06-21

6.  Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.

Authors:  Laurent Béchard; Olivier Corbeil; Maude Plante; Marc-André Thivierge; Charles-Émile Lafrenière; Marc-André Roy; Marie-France Demers
Journal:  J Psychopharmacol       Date:  2021-07-06       Impact factor: 4.153
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.